艾迪药业: 艾迪药业第三届董事会第五次会议决议公告

Meeting Overview - The third meeting of the board of directors of Jiangsu Aidi Pharmaceutical Group Co., Ltd. was held on August 14, 2025, with all 7 directors present, complying with relevant regulations [1]. Agenda Items - The board approved the adjustment of the 2025 stock option incentive plan, reducing the number of incentive recipients from 45 to 43 and the total stock options from 9.1 million to 8.96 million due to the departure of 2 recipients [1][2]. - The board agreed to grant stock options to the 2025 incentive recipients, with the grant date set for August 14, 2025, and a total of 8.96 million stock options to be issued at an exercise price of 13.01 yuan per share [2][3]. - The board approved the use of self-owned funds and bank acceptance bills to finance fundraising projects, which will be replaced by the raised funds, enhancing fund efficiency and reducing costs [3][4].